HIV/Antivirals
15 drugs in this class, prescribed by 56,963 Medicare Part D providers.
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$3.10B
Total Cost
1,687,070
Claims
15
Drugs
$1,840
Avg Cost/Claim
Key Insights
- Most expensive per prescription: Epclusa at $23K/claim
- Most prescribed: Valacyclovir with 827,731 claims
- This class represents 1.1% of total Medicare Part D spending
All HIV/Antivirals Drugs
| Drug | Cost | Claims |
|---|---|---|
| Bictegrav/Emtricit/Tenofov Ala | $1.29B | 310,738 |
| Dolutegravir Sodium | $251.7M | 102,995 |
| Abacavir/Dolutegravir/Lamivudi | $238.1M | 61,147 |
| Emtricitabine/Tenofov Alafenam | $222.4M | 94,580 |
| Dolutegravir Sodium/Lamivudine | $173.3M | 56,930 |
| Darunavir/Cob/Emtri/Tenof Alaf | $172.5M | 34,812 |
| Sofosbuvir/Velpatasvir | $149.4M | 6,544 |
| Dolutegravir/Rilpivirine | $148.9M | 41,081 |
| Emtricitab/Rilpiviri/Tenof Ala | $144.1M | 37,441 |
| Darunavir/Cobicistat | $99.7M | 38,374 |
| Tenofovir Alafenamide | $68.7M | 44,509 |
| Cabotegravir/Rilpivirine | $48.1M | 7,384 |
| Darunavir | $46.0M | 21,793 |
| Valacyclovir Hcl | $35.9M | 827,731 |
| Glecaprevir/Pibrentasvir | $14.1M | 1,011 |